Evidence map›Paper›PMID 42201850›Full record

ArticlePharmacology2026

Retraction Statement.

Abstract readRetraction Notice
PubMed Publisher
In one paragraph

Article in Pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

0 authors.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The article "Hypoxia-Treated Adipose Mesenchymal Stem Cells Derived Exosomes Enhance the Therapeutic Effects on Unilateral Ureteral Obstruction Mice" [Pharmacology. 2025;110(3):165-177; https://doi.org/10.1159/000542609] by Chi Zhang, Longjun Cai, Meimei Ma, Xiaohui Xie, Junsheng Wang and Yuanyuan Zhang has been retracted by the Publisher and the Editor.After the publication of this article, it was identified that Figure S1c in this article, depicting confirmation of the capability of the AMSCs for adipogenic differentiation, had been previously published as Figure 1C by a different author group depicting the capability of primary mouse BMSCs to differentiate to adipocytes [1].When asked to comment on the above, the authors stated that the image in question was provided by the stem cell distributor and that they did not conduct the differentiation experiments depicted in Figure S1, which was not disclosed in the article. As the authors did not disclose the source of the experiments and images in the figure in question and did not independently characterise the cell population before the study was conducted, the Editor concluded that the concerns undermined the results of the article and, therefore, the article has been retracted.The authors agreed to this retraction.

Identifiers

PMID42201850

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.